| Company* (Country; Symbol) | Company (Country; Symbol) | Type/Product Area | Terms/Details (Date) |
| I. MODIFIED AGREEMENTS | |||
| Althea Technologies Inc.* | BiPar Sciences Inc.* | Expanded collaboration to use Althea's genomic technology to validate cancer biomarkers and predict clinical outcomes in BiPar's oncology clinical trials | Terms were not disclosed (10/2) |
|
Notes: * Private companies are indicated with an asterisk. Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
To read more on related topics, click on one of the words below.